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Abstract
Objectives: To investigate polymorphism in exon 8 of the
SLC3A1 gene in children with urinary cystine calculi in
Khartoum.
Methods: A semi-quantitative chemical method was used
to analyse 175 urinary calculi removed surgically from
paediatric patients at Soba Teaching Hospital in Khar-
toum between October 2005 and May 2009. DNA was
extracted with phenol chloroform isoamyl alcohol, and
exon 8 of the SLC3A1 gene was amplified in a thermocycler
and sequenced with an AB3130 genetic autoanalyser.
Results: Of the 175 stones, 10 were cystine calculi (5.7%).
The sex ratio of the patients was 2.3:1 (boys to girls), and
themean age at cystine stone onset was 31.1 28.2months
(range, 3e125 months). Of the 10 patients, 8 had a positive
family history of calculi formation, 4 hadbilateral calculi, 3
had both renal and urinary bladder calculi, and 2 had
obstructive acute renal failure. All patients required more
than one surgical operation. One patient had a missense
mutationM467K in exon 8 of the SLC3A1 gene.
Conclusion: The prevalence of cystine calculi among uri-
nary calculi inSudanese childrenwas 5.7%.A familyhistory
was found in 80% of children. A mutation (M467T) was
identified at exon 8 of the SLC3A1 gene in one child.
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Elsevier Ltd. All rights reserved.Table 1: Demographic and clinical characteristics of 10 chil-
dren with cystine calculi.
Characteristic No.
Sex
Boys 7
Girls 3
Age (months)
Mean 31.9
Minimum 3
Maximum 125
Family history
Positive 8
Negative 2
Site of stone
Bilateral 4
Unilateral 2
Multiple (more than 1) 1
Both kidney and urinary bladder 3
Recurrent formation
>6 8
2e5 2
1 0
Initial clinical presentation
Non-specific 7
Urinary tract infection 3
Haematuria 1Introduction
Cystinuria is an autosomal recessive disorder that ac-
counts for up to 10% of all paediatric stone disease.1,2 It
causes failure in the reabsorption of filtered cystine and
dibasic amino acids in the proximal tubule,3 resulting in
recurrent stone formation, which leads to impairment of
renal function and quality of life.4
Cystine stones are radio-opaque, yellowewhite forma-
tions with a waxy lustre. The detection of cystine crystals
indicates the potential for cystine calculi. Hexagonal cystine
crystals occur frequently at any age but are infrequently seen
in infants.5
Cystinuria is a primary inherited aminoaciduria caused by
mutations in the genes that encode for the two subunits
(neutral and basic amino acid transport protein rBAT and
b0þ type amino acid transporter1) of the amino acid trans-
port system b0þ(3). SLC3A1 and SLC7A9 have been identified
as the genes responsible.6 The large majority of the more
than 200 mutations so far identified in the two genes are
point mutations, while only a few alleles carrying gross
genomic alterations have been reported.6 Mutations in the
SLC3AI gene encoding the glycoprotein rBAT cause
cystinuria type I, while variants in the SLC7A9 gene have
been found in non-type I cystinuria; its gene product
b0þAT is the light chain of the renal cystine transport system
rBAT/b0þAT.7,8 Point mutations in the two genes are
known to cause cystinuria.9
The clinically significant manifestations related to stone
formation include nausea, flank pain, haematuria, recurrent
urinary tract infections and, rarely, acute or chronic renal
failure.10 A high index of suspicion should be raised in
patients with a family history of cystinuria or stone disease,
recurrent crystalluria or stone formation in the first two
decades of life.11 There is no pathological correlation with
urinary excretion of the other dibasic amino acids,
ornithine, lysine and arginine.12 The gastrointestinal
implications of impaired absorption of cystine are of no
clinical significance, because cystine absorption is
maintained by the ability of the small intestine to absorb
oligopeptides containing cystine.10
Cystinuria may be particularly important in children, first
because it accounts for 6e8% (in some reports up to 10%) of
paediatric urinary calculi and only 1e2% in adults;2 and,
secondly, if the underlying problem is not properly
diagnosed and treated, there is a high risk for renal damage.1,13
More than 50% of cystinuric patients develop cystine
calculi during their lifetime.1 The reported rate of cystine
calculi among paediatric urolithiasis cases varies from 2%
in Armenia,14 Turkey15 and the USA16 to 2.4% in
Kuwait17 and up to 10% in Croatia.18 Only one study of
childhood and adult urolithiasis has previously been
performed in the Sudan, and no cystine stones were
detected.19 The aim of the study reported here was todetermine the prevalence of cystine stones in children with
urinary calculi and to investigate the genetic component.Materials and Methods
Of the 175 patients with urinary calculi referred for pae-
diatric surgery to the Soba Teaching Hospital in Khartoum
between October 2005 and May 2009, 10 had cystine stones.
After informed consent had been obtained from the patients
or their families, blood was taken for DNA testing. The
study was approved by the local medical authority.
Laboratory investigations were conducted in the
Research Laboratory at Sudan University of Science and
Technology, the Biotechnology Research Laboratory at
Yarmouk University, Irbid, Jordan, and the Princess Haya
Biotechnology Centre, Elrimtha, Jordan. The cyanidee
nitroprusside test was used to detect cystine stones.
DNA was extracted from blood samples by the phenol
chloroform isoamyl alcohol method.20 Polymerase chain
reaction (PCR) was used to amplify a 317-base pair frag-
ment of the SLC3A1 gene (exon 8) in chromosome 2
(2p16.3), with synthetic oligonucleotide primers comple-
mentary to the DNA sequence of these regions. The sense
primer strand, 50-tagggtaaatctttcagaaaact-30, and the
antisense-strand, 50-atagtaagttctctgatttggca-30, were synthe-
sized by Midland Certified Reagent Co. (Midland, Texas,
USA). Master mix was obtained from BioLabs (United
Kingdom), and nuclease-free water from Midland Certified
Reagent Co. (Midland, Texas, USA). PCR amplifications
were conducted on an X Bioer thermocycler (TC-96G,
China).
Each PCR reaction contained 25 mL of master mix (2X
Biolab), 2 mL of genomic DNA template (200 ng), 2 mL of
Figure 1: 317 bp of exon 8 in SLC3A1 cystinuria gene of patients
with cystine stones. Lane 1, ladder 100 bp (DNA marker); lane 2,
negative control; lane 17, positive control; amplicon lanes (3, 4, 5,
7, 9, 11, 12, 13, 14, 15, 16).
SLC3A1 polymorphism and urinary calculi 221each primer (5 pmol/mL), 1 mL of Taq polymerase and 18 mL
of nuclease-free water. The PCR conditions were: denaturing
at 95 C for 5 min, followed by 35 cycles at 95 C for 30 s,
annealing at 54.8 C for 40 s, extension at 72 C for 45 s and a
final extension at 72 C for 5 min.
For all PCR reactions, positive and negative controls were
run parallel to each test sample. For the positive control, all
reaction mixtures except template DNA and other known
DNA templates were used. For the negative control, all re-
action mixtures except template DNA were used, to ensure
the amplification quality. Amplicons were sequenced in an
Applied Biosystems 3130 genetic analyser.Figure 2: Spectrograph of mutant exon 8 at coding region in SLC3A1 g
317 bp.Results
Of the 175 patients with urinary calculi, 10 (5.7%) had
cystine stones. The demographic characteristics and clinical
data of these 10 patients are shown in Table 1. The mean age
of patients at presentation with a cystine stone was
31.9  28.2 months (range, 3e125 months). All the
patients required more than one surgical operation to
remove the stone; shockwave lithotripsy was used for eight
patients. Two had obstructive acute renal failure.
The PCR product and the 100-bp ladder (DNA marker)
were run in 3% agarose gel as shown in Figure 1. After
sequencing of the amplicon, only one sample showed a
substitution, which was at position 105 bp T to A in
amplicon 317 bp (Figure 2).Discussion
We found 10 cases of cystine stone among 175 children
admitted for urinary calculi to Soba Teaching Hospital dur-
ing the periodOctober 2005 toMay 2009. Cystine stones were
found in seven boys and three girls (ratio, 2.3:1). In a study of
four cases of urolithiasis in Tunisian children, three were in
boys and one in a girl.21 In a study in Jordan of 20 patients
with cystine calculi, 16 were male and 4 were female, but
only 4 were younger than 14 years.22 Cystinuria may
depend on the ethnic or geographical origin of the
population screened. The studies in Arab populations were
based on small numbers of patients and were mostly
epidemiological screening studies for urolithiasis.23
In our study, the mean age of disease onset was
31.9  28.2 months, the youngest being 3 months old.
Therefore, cystinuria should be considered a likely cause of
urolithiasis even in very young patients, and metabolic work-
up for cystinuria should be mandatory for young childrenene in cystine stones. Substitution of T to A at position 105 bp of
G.A. Elfadil et al.222presenting with urinary calculi. Significant differences in the
age at presentation with cystine calculi might be due to ge-
netic factors in the cystinuria patients who have been
studied.2
Seven of the 10 cases in this study were detected during
evaluation of nonspecific symptoms by ultrasonography.
Therefore, some cases of cystine calculi in adulthood may be
undiagnosed since infancy and childhood. Urinary tract
infection was present in three of our patients, and 10 pre-
sented with haematuria. This finding emphasizes the
importance of considering underlying metabolic disorders in
such conditions.
Bilateral nephrolithiasis was detected in four patients,
eight had more than six calculi, and seven had a positive
family history of cystine calculi. The presence of multiple
calculi, together with the recurrent nature of cystine calculi,
predispose patients to renal parenchymal damage.24
In this study, one patient had a substitution in one
nucleotide in exon 8 of the SLC3A1 gene, at position 105 T/A
in 317 bp of the amplicon, leading to a missense mutation,
M467K (methionine ATG to lysine AAG). The methionine
at position 467 is completely conserved in all the species in
which rBAT sequences have been identified.3,25 The
mutation leads to reduced transport activity of cystine and
diabasic amino acid.26 The M467T mutation has been
found in 26% of type I cystinuria chromosomes so far
analysed and was the only mutation found in a
homozygotic Spanish family.27 The related mutation
M467K was found to be heterozygous with the L678P
mutation in one Italian patient.6,28
Conclusion
For paediatric calculi, we recommend metabolic work-up
and screening for SLC3A1 and SLC7A9 genes to detect mu-
tations other thanM467T, such as missense, nonsense, splice
site and frame shifts as well as large deletions.
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